Table 2 Comparisons between controlled and uncontrolled patients- reference to office and home BP
|  | OBP < 140 and <90 and HBP < 135 and <85 | OBP ≥140 and/or ≥90 and HBP≥135 and/or ≥85 | P |
|---|---|---|---|
N | 15 | 34 | Â |
Age (years) | 53.4 ± 9.8 | 56.8 ± 11 | 0.33 |
Graft survival (years) | 5.3 ± 4 | 6.3 ± 6 | 0.82 |
Nephrectomy (native kidney), (N) | 1 | 5 | 0.65 |
Donor | Â | Â | Â |
Age (years) | 39.9 ±12.4 [17–54] | 42.7 ±16.5 [15–67] | 0.44 |
Hypertension, (N) | 3 | 5 | 0.69 |
Cadaveric, (N) | 14 | 34 | 0.31 |
Living, (N) | 1 | 0 | 0.31 |
Office SBP (mmHg) | 125 ± 9 | 146 ± 12 | 0.000002 |
Office DBP (mmHg) | 77 ± 8 | 87 ± 13 | 0.004 |
Office heart rate (beat/min) | 67 ± 9 | 69 ± 12 | 0.78 |
Home SBP (mmHg) | 123 ± 7 | 141 ± 10 | 0.000001 |
Home DBP (mmHg) | 77 ± 6 | 85 ± 11 | 0.0005 |
Home heart rate (beat/min) | 68 ± 5 | 70 ± 12 | 0.81 |
Hemodialysis vintage (years) | 4.0 ± 7 | 2.6 ± 2 | 0.44 |
BMI (kg/m2) | 24 ± 4.6 | 26 ± 4.9 | 0.18 |
Number of antihypertensive drugs | 2.1 ± 1 | 2.1 ± 1 | 0.99 |
GFR(ml/min) | 63.2 ± 28 | 61.5 ± 21 | 0.94 |
Calcineurin inhibitors N(%) | 14 (93) | 31 (91) | 1.00 |
Cyclosporine | 2 (13) | 14 (41) | 0.045 |
Tacrolimus | 12 (80) | 17 (50) | Â |
Prednisone (daily dose) | 3.9 ± 1.2 | 4.7 ± 1 | 0.09 |
K + (blood;mmol/l) | 3.9 ±0.3 [3.1-4.5] | 4 ± 0.4 [3.2-5] | 0.56 |
Urinary excretion | Â | Â | Â |
Diuresis (ml) | 2431 ± 719 | 2457 ± 919 | 0.90 |
Na+ (mmol/24 h) | 154 ± 93 | 162 ± 88 | 0.60 |
K+ (mmol/24 h) | 68 ± 14 | 54 ± 20 | 0.029 |
Na+/K+ ratio [CI 95%] | 2.3 ± 1.2 [1.6-3.1] | 3.2 ± 1.3 [2.7-3.6] | 0.052 |
NaCl (g/24 h) | 9.1 ± 5.4 | 9.6 ± 5.2 | 0.60 |
Diet intakes | Â | Â | Â |
Na+ (mg/24 h) | 2339 ± 1067 | 1766 ± 695 | 0.23 |
K+ (mg/24 h) | 3279 ± 753 | 2208 ± 720 | 0.009 |